News

Angi Calkins Appointed as Chief Human Resources Officer

Calkins to lead global human resource team during time of considerable expansion PCI is pleased to announce the appointment of Angi Calkins as Senior Vice President and Chief Human Resources Officer. Angi joins PCI as we experience considerable growth and global expansion, currently with more than 3,500 associates, spanning eight locations comprised of 20 facilities […]

Expansion of Controlled Substance Storage to Support Blister Packaging Capacity for Opioids

PCI stands ready to support controlled substance storage and packaging changes brought in by new Opioid legislation PCI Is pleased to announce further investment in our expansive infrastructure controlled substance storage and packaging, complementing our industry-leading capacity for blister packaging, a key tenet of recent calls for dispensing opioid prescriptions in limited quantity unit dose […]

PCI Brexit Communication, 17th January 2019

The UK Parliament voted on 15th January 2019 rejecting the EU/UK Brexit deal and therefore, a number of unknown variables regarding the current Brexit situation remain. As the position of Brexit evolves over the coming days and weeks, PCI expects to gain additional clarity and will be advising of any implications to supply chains. PCI […]

PCI Brexit Communication, 16 January 2019

The UK Parliament voted on 15th January 2019 rejecting the EU/UK Brexit deal and therefore, a number of unknown variables regarding the current Brexit situation remain. As the position of Brexit evolves over the coming days and weeks, PCI expects to gain additional clarity and will be advising of any implications to supply chains. PCI […]

$20 Million Expansion of Biotech Technologies Including Advanced Injectable Delivery Forms

Demand for Biotech packaging drives significant PCI investment at multiple locations world wide PCI is pleased to announce a momentous investment in support of biologic medicines and advanced injectable delivery forms, totaling more than $20 million. We will add expanded Biotech clinical and commercial packaging and release testing capability at our Center of Excellence in […]

Specialist 2-8°C Cold Chain Capabilities Become Operational at Hay-on-Wye, UK Site

Hay-on-Wye Center of Excellence increases capacity for onsite 2-8°C Cold Chain storage. PCI is pleased to announce a significant expansion of our onsite Cold Chain storage capabilities at our Hay-on-Wye, UK site. The announcement is the latest in a series of strategic investments, demonstrating our market-leading presence in Biotech therapies, supporting medicines destined reach to […]

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients